CRISPR 시장 : 예측(2025-2030년)

The CRISPR market is expected to grow from USD 5.565 billion in 2025 to USD 9.551 billion in 2030, at a CAGR of 11.41%.

The global CRISPR market represents a rapidly expanding biotechnology sector driven by significant investments from developed nations and the revolutionary potential of Clustered Regularly Interspaced Short Palindromic Repeats technology. This cutting-edge genome editing tool has transformed multiple industries including genetic engineering, biotechnology, pharmaceuticals, and agriculture, establishing itself as a cornerstone technology for modern molecular research and therapeutic development.

Technology Applications and Market Foundation

CRISPR technology enables precise genome editing through molecular machinery and designed nucleases, facilitating deletions, insertions, or substitutions in living organism DNA. The technology supports diverse applications including gene disruption, homologous gene direct repair, and gene library development containing cloned DNA fragments with functional gene information. CRISPR plasmids have become essential tools for researchers requiring precise genetic modifications across multiple research domains.

The versatility of CRISPR applications extends beyond traditional research settings into commercial agricultural development, where gene-edited crops offer enhanced nutritional profiles and improved consumer acceptance characteristics. Additionally, the technology supports advanced gene delivery systems and viral vector applications, expanding therapeutic possibilities for complex genetic conditions.

Primary Market Growth Drivers

Extensive Application Portfolio

CRISPR's broad application spectrum drives sustained market expansion across multiple sectors. Genome editing capabilities enable researchers to address complex genetic challenges while supporting biotechnology companies in developing innovative solutions for agricultural, pharmaceutical, and therapeutic applications. The technology's adaptability across diverse research contexts creates sustained demand from academic institutions, biotechnology companies, and pharmaceutical enterprises.

Rising Genetic Disorder Prevalence

The increasing incidence of genetic disorders significantly expands market demand for CRISPR technologies. Genetic illnesses, while individually rare, constitute approximately 80% of rare disorders globally, affecting substantial patient populations requiring innovative therapeutic approaches. This demographic reality creates sustained demand for gene editing technologies capable of addressing previously untreatable genetic conditions.

Advanced gene therapy applications targeting severe illnesses demonstrate CRISPR's therapeutic potential, with biotechnology companies developing collaborative approaches to address rare diseases including amyotrophic lateral sclerosis and Friedreich's ataxia through innovative gene-based treatments.

Research and Development Acceleration

Extensive research and development activities provide significant opportunities for market participants across multiple therapeutic areas. Cancer research particularly benefits from CRISPR technology, as researchers transition from laboratory applications to clinical testing involving CRISPR-edited immune cells designed to enhance cancer detection and treatment capabilities.

The technology addresses long-standing challenges in gene editing by providing rapid, simple, and cost-effective solutions that meet researcher requirements across diverse applications. This accessibility drives adoption across research institutions and commercial enterprises seeking efficient genetic modification tools.

Market Constraints and Challenges

Awareness and Education Limitations

Insufficient awareness regarding CRISPR technology's extensive applications represents a primary market constraint, particularly in developing regions across Asia and Africa. Limited understanding of the technology's potential applications in research initiatives restricts market penetration and adoption rates among potential users who could benefit from genetic editing capabilities.

Regulatory and Ethical Considerations

Potential misuse concerns regarding CRISPR gene editing technologies present ongoing challenges for market development. Regulatory frameworks and ethical guidelines continue evolving to address safety and application boundaries, creating uncertainty that may impact adoption rates and commercial development timelines.

Geographic Market Dynamics

North America maintains significant market leadership driven by thriving pharmaceutical and biotechnology industries, widespread technology adoption, and increasing research and development activities. The region benefits from established healthcare infrastructure, rising healthcare expenditures, and strong demand for genetically modified organisms and human stem cell applications.

Strategic Implications

The CRISPR market presents substantial growth opportunities driven by technological versatility, increasing genetic disorder prevalence, and accelerating research activities. Success requires addressing awareness gaps through education initiatives while navigating evolving regulatory landscapes. Market participants must balance innovation with responsible development practices to maximize growth potential across diverse application areas and geographic markets.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Global CRISPR Market Segments:

By Type

• Class 1
• Class 2

By Application

• Cell & Gene Therapies
• Disease Diagnostics
• Drug Development
• Others

By End-User

• Pharmaceuticals & Biotechnology Company
• Academic & Research Institutes
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Taiwan
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CRISPR MARKET BY TYPE

• 5.1. Introduction
• 5.2. Class 1
• 5.3. Class 2

6. GLOBAL CRISPR MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Cell & Gene Therapies
• 6.3. Disease Diagnostics
• 6.4. Drug Development
• 6.5. Others

7. GLOBAL CRISPR MARKET BY END-USER

• 7.1. Introduction
• 7.2. Pharmaceuticals & Biotechnology Company
• 7.3. Academic & Research Institutes
• 7.4. Others

8. GLOBAL CRISPR MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Israel
  • 8.5.4. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Taiwan
  • 8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Addgene
• 10.2. CRISPR Therapeutics
• 10.3. Editas Medicine
• 10.4. GenScript Biotech Corporation
• 10.5. Horizon Discovery (PerkinElmer)
• 10.6. Integrated DNA Technologies, Inc.
• 10.7. Intellia Therapeutics, Inc.
• 10.8. Thermo Fisher Scientific Inc.
• 10.9. Sigma-Aldrich
• 10.10. Caribou Biosciences, Inc.

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key benefits for the stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations